# Bioequivalence Study Comparing Two Pomalidomide 4 mg Capsule Formulations in Healthy Male Subjects

> **NCT07694011** · PHASE1 · COMPLETED · sponsor: **Knight Therapeutics (USA) Inc** · enrollment: 34 (actual)

## Conditions studied

- Pomalidomide Bioequivalence Study in Healthy Volunteers

## Interventions

- **DRUG:** Xetrane® (Pomalidomide) 4 mg Hard Capsule
- **DRUG:** Imnovid® (Pomalidomide) 4 mg Hard Capsule

## Key facts

- **NCT ID:** NCT07694011
- **Lead sponsor:** Knight Therapeutics (USA) Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-25
- **Primary completion:** 2025-02-05
- **Final completion:** 2025-02-07
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2026-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07694011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07694011, "Bioequivalence Study Comparing Two Pomalidomide 4 mg Capsule Formulations in Healthy Male Subjects". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07694011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*